TY - JOUR
T1 - Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
AU - Raatikainen, M J Pekka
AU - Hakalahti, Antti
AU - Uusimaa, Paavo
AU - Nielsen, Jens Cosedis
AU - Johannessen, Arne
AU - Hindricks, Gerhard
AU - Walfridsson, Håkan
AU - Pehrson, Steen
AU - Englund, Anders
AU - Hartikainen, Juha
AU - Kongstad Rasmussen, Ole
AU - Mortensen, Leif Spange
AU - Hansen, Peter Steen
PY - 2015
Y1 - 2015
N2 - The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) is a randomized trial comparing radiofrequency catheter ablation (RFA) to antiarrhythmic drugs (AADs) as first-line treatment of paroxysmal atrial fibrillation (PAF). In order to eliminate the clouding effect of crossover we performed an on-treatment analysis of the data.
AB - The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) is a randomized trial comparing radiofrequency catheter ablation (RFA) to antiarrhythmic drugs (AADs) as first-line treatment of paroxysmal atrial fibrillation (PAF). In order to eliminate the clouding effect of crossover we performed an on-treatment analysis of the data.
U2 - 10.1016/j.ijcard.2015.06.160
DO - 10.1016/j.ijcard.2015.06.160
M3 - Article
C2 - 26163901
SN - 0167-5273
VL - 198
SP - 108
EP - 114
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -